Seventh FDA/Alzheimer’s Disease Allies Meeting
ACT-AD hosted its Seventh FDA/Alzheimer’s Disease Allies Meeting for patient groups, regulators, researchers and industry. This meeting explored challenges related to clinical meaningfulness in therapeutic development for early Alzheimer’s disease.
See Dr. Kun Jin’s Presentation
See Dr. Richard Keefe’s Presentation
See Dr. Paul Aisen’s Presentation
More Upcoming Events
Sep05A limited number of guest rooms are available at the Hyatt Regency Bethesda at the…